In a Dec. 22 story about obesity drugs, The Associated Press erroneously reported when Orexigen Therapeutics Inc. plans to file for approval of its drug candidate Contrave32. It plans to file in the first half of 2010, not by the end of the year.
7 Simple Steps to Eliminate School Shootings Overnight
Liberals Fail, Volume XXXVII
Israel Figured Out How to Prevent School Shootings 40 Years Ago-It's Time the US Followed Suit